Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Ticagrelor in Patients with Stable Coronary Disease and Diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac Surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Dangers of hyperoxia

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Letter the editor: serious methodological concerns about a recently published meta-analysis on oxygen therapy

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  • Olav L Schjørring
  • Thomas L Klitgaard
  • Anders Perner
  • Jørn Wetterslev
  • Theis Lange
  • Martin Siegemund
  • Minna Bäcklund
  • Frederik Keus
  • Jon H Laake
  • Matthew Morgan
  • Katrin M Thormar
  • Søren A Rosborg
  • Jannie Bisgaard
  • Annette E S Erntgaard
  • Anne-Sofie H Lynnerup
  • Rasmus L Pedersen
  • Elena Crescioli
  • Theis C Gielstrup
  • Meike T Behzadi
  • Lone M Poulsen
  • Stine Estrup
  • Jens P Laigaard
  • Cheme Andersen
  • Camilla B Mortensen
  • Björn A Brand
  • Jonathan White
  • Inge-Lise Jarnvig
  • Morten H Møller
  • Lars Quist
  • Morten H Bestle
  • Martin Schønemann-Lund
  • Maj K Kamper
  • Mathias Hindborg
  • Alexa Hollinger
  • Caroline E Gebhard
  • Núria Zellweger
  • Christian S Meyhoff
  • Mathias Hjort
  • Laura K Bech
  • Thorbjørn Grøfte
  • Helle Bundgaard
  • Lars H M Østergaard
  • Maria A Thyø
  • Thomas Hildebrandt
  • Bülent Uslu
  • Christoffer G Sølling
  • Nette Møller-Nielsen
  • Ulf Gøttrup Pedersen
  • Anne S Andreasen
  • Janus Engstrøm
  • Maj-Brit N Kjær
  • HOT-ICU Investigators
  • Diana Bertelsen Jensen (Medlem af forfattergruppering)
  • Kasper Mørk Sørensen (Medlem af forfattergruppering)
  • Patrick Sprogøe Rasmussen (Medlem af forfattergruppering)
  • Andreas Rovsing Hjortdal (Medlem af forfattergruppering)
  • Nanna Reiter (Medlem af forfattergruppering)
  • Niels Erikstrup Clausen (Medlem af forfattergruppering)
  • Lars Hein (Medlem af forfattergruppering)
  • Michael Ibsen (Medlem af forfattergruppering)
  • Sigurður Þór Sigurðsson (Medlem af forfattergruppering)
Vis graf over relationer

BACKGROUND Patients with acute hypoxemic respiratory failure in the intensive care unit (ICU) are treated with supplemental oxygen, but the benefits and harms of different oxygenation targets are unclear. We hypothesized that using a lower target for partial pressure of arterial oxygen (Pao 2) would result in lower mortality than using a higher target. METHODS In this multicenter trial, we randomly assigned 2928 adult patients who had recently been admitted to the ICU (≤12 hours before randomization) and who were receiving at least 10 liters of oxygen per minute in an open system or had a fraction of inspired oxygen of at least 0.50 in a closed system to receive oxygen therapy targeting a Pao 2 of either 60 mm Hg (lower-oxygenation group) or 90 mm Hg (higher-oxygenation group) for a maximum of 90 days. The primary outcome was death within 90 days. RESULTS At 90 days, 618 of 1441 patients (42.9%) in the lower-oxygenation group and 613 of 1447 patients (42.4%) in the higher-oxygenation group had died (adjusted risk ratio, 1.02; 95% confidence interval, 0.94 to 1.11; P=0.64). At 90 days, there was no significant between-group difference in the percentage of days that patients were alive without life support or in the percentage of days they were alive after hospital discharge. The percentages of patients who had new episodes of shock, myocardial ischemia, ischemic stroke, or intestinal ischemia were similar in the two groups (P=0.24). CONCLUSIONS Among adult patients with acute hypoxemic respiratory failure in the ICU, a lower oxygenation target did not result in lower mortality than a higher target at 90 days.

OriginalsprogEngelsk
TidsskriftThe New England journal of medicine
Vol/bind384
Udgave nummer14
Sider (fra-til)1301-1311
Antal sider11
ISSN0028-4793
DOI
StatusUdgivet - 8 apr. 2021

ID: 61828500